The prevalence of frontotemporal dementia
Abstract
Objective: To estimate the prevalence of frontotemporal dementia (FTD) and other degenerative early-onset dementias in a geographically defined population.
Background: Early-onset dementia (at age <65 years) results in high psychiatric morbidity and caregiver burden. Prevalence figures are available for early-onset AD but not for FTD, a dementia that is almost invariably of early onset.
Methods: Case ascertainment was by review of case records of three specialist clinic databases and inpatient admissions at a university hospital in Cambridge, United Kingdom, for patients with dementia who were <65 years of age, living in Cambridge City or East or South Cambridgeshire (population 326,019) on May 30, 2000. All the relevant health services in the area were also contacted for potential cases. Diagnosis of various dementias was based on published criteria. All patients with potential FTD were examined by the study investigators and underwent structural neuroimaging. The 1998 population estimates for the area were used to calculate age and sex prevalence with confidence intervals for AD, FTD, and other causes of dementia.
Results: A total of 108 patients (66 men and 42 women) with dementia with onset before they were 65 years of age were identified, of whom 60 were <65 years on the census date, giving an overall prevalence of 81 (95% CI, 62.8 to 104.5) per 100,000 in the 45- to 64-year age group. The prevalences of early-onset FTD and AD were the same: 15 per 100,000 (8.4 to 27.0) in the 45- to 64-year-old population. The mean age at onset of FTD was 52.8 years and there was a striking male preponderance (14:3). It is possible case ascertainment methods resulted in a relative underrepresentation of some forms of dementia.
Conclusions: Frontotemporal dementia is a more common cause of early-onset dementia than previously recognized and appears to be more common in men.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Baldwin RC. Acquired cognitive impairment in the presenium. Psychiatr Bull . 1994; 18: 463–465.
2.
Ferran J, Wilson K, Doran M, et al. The early onset dementias: a study of clinical characteristics and service use. Int J Geriatr Psychiatry . 1996; 11: 863–869.
3.
McGonigal G, Thomas B, McQuade C, Starr JM, MacLennan WJ, Whalley LJ. Epidemiology of Alzheimer’s presenile dementia in Scotland, 1974–88. BMJ . 1993; 306: 680–683.
4.
Newens AJ, Forster DP, Kay DW, Kirkup W, Bates D, Edwardson J. Clinically diagnosed presenile dementia of the Alzheimer type in the northern health region: ascertainment, prevalence, incidence and survival. Psychol Med . 1993; 23: 631–644.
5.
Treves T, Korczyn ADK, Zilber N, et al. Presenile dementia in Israel. Arch Neurol . 1986; 43: 26–29.
6.
Mendez MF, Selwood A, Mastri AR, Frey WH II . Pick’s disease versus Alzheimer’s disease: a comparison of clinical characteristics. Neurology . 1993; 43: 289–292.
7.
Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology . 1998; 51: 1546–1554.
8.
Neary D, Snowden JS, Bowen DM, et al. Neuropsychological syndromes in presenile dementia due to cerebral atrophy. J Neurol Neurosurg Psychiatry . 1986; 49: 163–177.
9.
Gustafson L. The clinical picture of frontal lobe degeneration of non-Alzheimer type. Dementia . 1993; 4: 143–148.
10.
Spillantini MG, Van Swieten JC, Goedert M. Tau gene mutations in frontotemporal dementia and Parkinsonism linked to chromosome 17 (FTDP-17). Neurogenetics . 2000; 2: 193–205.
11.
Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5′splice-site mutations in tau with the inherited dementia FTDP-17. Nature . 1998; 393: 702–705.
12.
Poorkaj P, Bird TD, Wijsman E, et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol . 1998; 43: 815–818.
13.
Harvey RJ, Rossor MN, Skelton-Robinson M, Garralda E. Young onset dementia: epidemiology, clinical symptoms, family burden, support and outcome, 1998. Available at: www. dementia.ion.ac.uk.
14.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd ed revised. Washington, DC: American Psychiatric Association, 1987.
15.
Bozeat S, Gregory CA, Ralph MA, Hodges JR. Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer’s disease. J Neurol Neurosurg Psychiatry . 2000; 69: 178–186.
16.
Mathuranath PS, Nestor P, Berrios GE, Rakowicz W, Hodges JR. A brief cognitive test battery to differentiate Alzheimer’s disease and frontotemporal dementia. Neurology . 2000; 55: 1613–1620.
17.
Hodges JR, Berrios GE, Breen K. The multidisciplinary memory clinic approach in memory disorders in psychiatric practice. In: Berrios GE, Hodges JR, eds. Memory disorders in psychiatric practice. Cambridge: Cambridge University Press, 2000: 101–121.
18.
World Health Organization. The ICD-10 classification of mental and behavioral disorders: clinical descriptions and diagnostic guidelines, 10th ed. Geneva: World Health Organization, 1992.
19.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology . 1984; 34: 939–944.
20.
Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology . 1996; 47: 1–9.
21.
McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. Neurology . 1996; 47: 1113–1124.
22.
Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN international workshop. Neurology . 1993; 43: 250–260.
23.
Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson’s disease. Ann Neurol . 1992; suppl: 125–127.
24.
Quinn N. Multiple system atrophy: the nature of the beast. J Neurol Neurosurg Psychiatry . 1989; suppl: 78–89.
25.
Brun A. Frontal lobe degeneration of non-Alzheimer type: 1: neuropathology. Arch Gerontol Geriatr . 1987; 6: 193–208.
26.
Knopman DS, Mastri AR, Frey WH II, Sung JH, Rustan T. Dementia lacking distinctive histologic features: a common non-Alzheimer degenerative dementia. Neurology . 1990; 40: 251–256.
27.
Mann DMA, South PW, Snowden JS, Neary D. Dementia of frontal lobe type: neuropathology and immunohistochemistry. J Neurol Neurosurg Psychiatry . 1993; 56: 605–614.
28.
Altman G, Machin D, Bryant TN, Gardner MJ, eds. Statistics with confidence, 2nd ed. London: British Medical Journal Publishing Co., 2000.
29.
Stevens M, Van Duijn CM, Kamphorst W, et al. Familial aggregation in frontotemporal dementia. Neurology . 1998; 50: 1541–1545.
30.
Neary D, Snowden JS, Northen B, Goulding P. Dementia of frontal lobe type. J Neurol Neurosurg Psychiatry . 1988; 51: 353–361.
31.
Sulkava R, Wikstrom J, Aromaa A, et al. Prevalence of severe dementia in Finland. Neurology . 1985; 35: 1025–1029.
32.
Kokmen E, Beard CM, Offord KP, Kurland LT. Prevalence of medically diagnosed dementia in a defined United States population: Rochester, Minnesota, January 1, 1975. Neurology . 1989; 39: 773–776.
33.
Molsa P, Marttila RJ, Rinne UK. Epidemiology of dementia in a Finnish population. Acta Neurol Scand . 1982; 65: 541–552.
34.
Schoenberg BS, Anderson DW, Haerer AF. Severe dementia: prevalence and clinical features in a biracial US population. Arch Neurol . 1985; 42: 740–743.
35.
Varma AR, Snowden JS, Lloyd JJ, Talbot PR, Mann DMA, Neary D. Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer’s disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry . 1999; 66: 184–188.
36.
Litvan I, Agid Y, Sastrj N, et al. What are the obstacles for an accurate clinical diagnosis of Pick’s disease? A clinicopathologic study. Neurology . 1997; 49: 62–69.
37.
Lopez OL, Litvan I, Catt KE, et al. Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias. Neurology . 1999; 53: 1292–1299.
38.
Heston LL, White JA, Mastri AR. Pick’s disease: clinical genetics and natural history. Arch Gen Psychiatry . 1987; 44: 409–411.
39.
Mathuranath PS, Xeureb JH, Bak T, et al. Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literature. J Neurol Neurosurg Psychiatry . 2000; 68: 304–312.
40.
Kertesz A, Martinez-Lage P, Davidson W, Munoz DG. The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology . 2000; 55: 1368–1375.
41.
Kertesz A, Munoz DG. Diagnostic controversies: is corticobasal degeneration part of the “Pick complex.” Adv Neurol . 2000; 82: 223–231.
42.
Harper PS, ed. Huntington’s disease, 2nd ed. London: WB Saunders, 1991.
43.
Critchley M. Huntington’s chorea and East Anglia. J State Med . 1934; 42: 575–587.
Information & Authors
Information
Published In
Copyright
© 2002.
Publication History
Received: July 16, 2001
Accepted: February 8, 2002
Published in print: June 11, 2002
Published online: July 2, 2023
Authors
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Retinal biomarkers for the risk of Alzheimer’s disease and frontotemporal dementia, Frontiers in Aging Neuroscience, 16, (2025).https://doi.org/10.3389/fnagi.2024.1513302
- Potential role of solid lipid curcumin particle (SLCP) as estrogen replacement therapy in mitigating TDP-43-related neuropathy in the mouse model of ALS disease, Experimental Neurology, 383, (114999), (2025).https://doi.org/10.1016/j.expneurol.2024.114999
- Neuroimaging in dementia, Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease, (213-224), (2025).https://doi.org/10.1016/B978-0-443-19041-4.00070-4
- Are We Missing Early-onset Frontotemporal Dementia as Late-onset Primary Psychiatric Disorder? A Case Series, Annals of Indian Psychiatry, 8, 1, (67-70), (2024).https://doi.org/10.4103/aip.aip_175_23
- Serum Beta-Secretase 1 Activity Is a Potential Marker for the Differential Diagnosis between Alzheimer’s Disease and Frontotemporal Dementia: A Pilot Study, International Journal of Molecular Sciences, 25, 15, (8354), (2024).https://doi.org/10.3390/ijms25158354
- Unveiling New Genetic Variants Associated with Age at Onset in Alzheimer’s Disease and Frontotemporal Lobar Degeneration Due to C9orf72 Repeat Expansions, International Journal of Molecular Sciences, 25, 13, (7457), (2024).https://doi.org/10.3390/ijms25137457
- Mutational Landscape of Alzheimer’s Disease and Frontotemporal Dementia: Regional Variances in Northern, Central, and Southern Italy, International Journal of Molecular Sciences, 25, 13, (7035), (2024).https://doi.org/10.3390/ijms25137035
- Case report: Assessing criminal responsibility and recidivism risk in the behavioral variant of frontotemporal dementia, Frontiers in Psychiatry, 15, (2024).https://doi.org/10.3389/fpsyt.2024.1437363
- Identifying clinical phenotypes of frontotemporal dementia in post-9/11 era veterans using natural language processing, Frontiers in Neurology, 15, (2024).https://doi.org/10.3389/fneur.2024.1270688
- Plasma Neurofilament Light Relates to Divergent Default and Salience Network Connectivity in Alzheimer’s Disease and Behavioral Variant Frontotemporal Dementia, Journal of Alzheimer’s Disease, 99, 3, (965-980), (2024).https://doi.org/10.3233/JAD-231251
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.